News
Roche announces FDA approval of Gavreto for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer
Roche announced that the United States (US) FDA has approved Gavreto™ (pralsetinib) for the treatment of adults with metastatic rearranged during transfection (RET) fusion-positive non-small...
Clinical Trials
Merck announces positive results phase 3 trials of gefapixant 45 mg twice daily in patients with refractory or unexplained chronic cough
Merck, known as MSD outside the United States and Canada, has announced the results from two pivotal phase 3 trials (COUGH-1 and COUGH-2) evaluating the...
News
Mylan to Acquire Aspen’s Thrombosis Business in Europe
Mylan N.V. announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited's thrombosis business in Europe for EUR...
News
Bayer completes acquisition of UK-based biotech company KaNDy Therapeutics Ltd
Bayer, a global leader in women’s healthcare, announced that, further to its press release of August 11, 2020, it has now completed the acquisition of...
News
Eisai to Take over Manufacturing and Marketing Approval for Equfina 50mg Tablets in Japan from Meiji Seika Pharma
Eisai Co., Ltd. announced that it will take over by transfer the manufacturing and marketing approval of Parkinson's disease treatment Equfina 50mg TABLETS (safinamide mesilate,...
News
China shows off Covid-19 vaccines for first time
China has put its homegrown coronavirus vaccines on display for the first time, as the country where the contagion was discovered looks to shape the...
Clinical Trials
Sinovac Biotech’s COVID-19 vaccine enters phase 3 trial globally
A COVID-19 vaccine candidate developed by Beijing-based Sinovac Life Sciences Corp has obtained preliminary approval in Bangladesh for entering phase III clinical trials, the company.
"Our...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.